158 related articles for article (PubMed ID: 17050865)
1. Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.
Agulnik M; Oza AM; Pond GR; Siu LL
J Clin Oncol; 2006 Oct; 24(30):4801-7. PubMed ID: 17050865
[TBL] [Abstract][Full Text] [Related]
2. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
Klitzman R
Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
[TBL] [Abstract][Full Text] [Related]
3. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer.
Seah DS; Scott S; Guo H; Najita J; Lederman R; Frank E; Sohl J; Stadler Z; Silverman S; Peppercorn J; Winer E; Come S; Lin NU
Oncologist; 2015 Sep; 20(9):992-1000. PubMed ID: 26240134
[TBL] [Abstract][Full Text] [Related]
4. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
[TBL] [Abstract][Full Text] [Related]
5. Performance of biopsies in clinical research.
Cannistra SA
J Clin Oncol; 2007 Apr; 25(11):1454-5. PubMed ID: 17416872
[No Abstract] [Full Text] [Related]
6. Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation.
Helft PR; Daugherty CK
J Clin Oncol; 2006 Oct; 24(30):4793-5. PubMed ID: 17050863
[No Abstract] [Full Text] [Related]
7. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
Bramstedt KA; Kassimatis K
Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
[TBL] [Abstract][Full Text] [Related]
8. Ethical and institutional review board issues.
Skolnick BE
Adv Neurol; 1998; 76():253-62. PubMed ID: 9408484
[TBL] [Abstract][Full Text] [Related]
9. Nurses on hospital IRBs: a critical voice in protecting human subjects.
Cassidy VR; Oddi LF
Nursingconnections; 1993; 6(1):31-8. PubMed ID: 8487874
[TBL] [Abstract][Full Text] [Related]
10. Exception from informed consent enrollment in emergency medical research: attitudes and awareness.
Triner W; Jacoby L; Shelton W; Burk M; Imarenakhue S; Watt J; Larkin G; McGee G
Acad Emerg Med; 2007 Feb; 14(2):187-91. PubMed ID: 17267533
[TBL] [Abstract][Full Text] [Related]
11. Bereavement practices of physicians in oncology and palliative care.
Chau NG; Zimmermann C; Ma C; Taback N; Krzyzanowska MK
Arch Intern Med; 2009 May; 169(10):963-71. PubMed ID: 19468090
[TBL] [Abstract][Full Text] [Related]
12. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology.
Kuerer HM; Eberlein TJ; Pollock RE; Huschka M; Baile WF; Morrow M; Michelassi F; Singletary SE; Novotny P; Sloan J; Shanafelt TD
Ann Surg Oncol; 2007 Nov; 14(11):3043-53. PubMed ID: 17828575
[TBL] [Abstract][Full Text] [Related]
13. Physicians' understanding of consent requirements for phase I clinical trials in cognitively impaired or highly vulnerable populations.
Farber NJ; Aboff BM; DeJoseph MR; Castellano J; Weiner J; Boyer EG
Account Res; 2004; 11(1):63-78. PubMed ID: 15341047
[TBL] [Abstract][Full Text] [Related]
14. [Comparing ethics committees from France and Quebec with respect to incapacity to consent to research].
Bravo G; Dubois MF; Hansel S; Delpierre C; Duguet AM
Rev Epidemiol Sante Publique; 2009 Aug; 57(4):231-9. PubMed ID: 19540684
[TBL] [Abstract][Full Text] [Related]
15. Inventors as investigators: the ethics of patents in clinical trials.
Kimmelman J
Acad Med; 2007 Jan; 82(1):24-31. PubMed ID: 17198287
[TBL] [Abstract][Full Text] [Related]
16. Quality assurance questionnaire for professionals fails to improve the quality of informed consent.
Lavori PW; Wilt TJ; Sugarman J
Clin Trials; 2007; 4(6):638-49. PubMed ID: 18042573
[TBL] [Abstract][Full Text] [Related]
17. Death in gene therapy trial raises questions about private IRBs.
Ledford H
Nat Biotechnol; 2007 Oct; 25(10):1067. PubMed ID: 17921976
[No Abstract] [Full Text] [Related]
18. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
[TBL] [Abstract][Full Text] [Related]
19. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
[TBL] [Abstract][Full Text] [Related]
20. [Clinical research and Huriet's law in medical oncology. Results of a French investigation among medical oncologists].
Hoerni B
Bull Cancer; 1997 Mar; 84(3):305-10. PubMed ID: 9207877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
